Zane M. Ellen's most recent trade in Synchrony Financial was a trade of 17 Dividend Equivalent Unit done at an average price of $60.5 . Disclosure was reported to the exchange on May 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 60.47 per share. | 15 May 2025 | 17 | 28,239 (0%) | 0% | 60.5 | 1,028 | Dividend Equivalent Unit |
| Boston Scientific Corp. | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 2,081 | 37,025 (0%) | 0% | 0 | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 52.94 per share. | 31 Mar 2025 | 1,039 | 28,222 (0%) | 0% | 52.9 | 55,005 | Common Stock |
| Boston Scientific Corp. | Ellen M. Zane | Director | Sale of securities on an exchange or to another person at price $ 104.23 per share. | 24 Feb 2025 | 13,586 | 34,944 (0%) | 0% | 104.2 | 1,416,134 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 65.31 per share. | 18 Feb 2025 | 13 | 27,183 (0%) | 0% | 65.3 | 849 | Dividend Equivalent Unit |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 65.01 per share. | 31 Dec 2024 | 635 | 27,170 (0%) | 0% | 65.0 | 41,281 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 65.00 per share. | 15 Nov 2024 | 15 | 26,535 (0%) | 0% | 65 | 975 | Dividend Equivalent Unit |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 49.88 per share. | 30 Sep 2024 | 827 | 26,520 (0%) | 0% | 49.9 | 41,251 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 45.87 per share. | 15 Aug 2024 | 23 | 25,693 (0%) | 0% | 45.9 | 1,055 | Dividend Equivalent Unit |
| Haemonetics Corp. | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2024 | 2,207 | 16,680 (0%) | 0% | - | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 47.19 per share. | 30 Jun 2024 | 875 | 25,670 (0%) | 0% | 47.2 | 41,291 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 44.15 per share. | 15 May 2024 | 26 | 24,795 (0%) | 0% | 44.2 | 1,148 | Dividend Equivalent Unit |
| Boston Scientific Corp. | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 2,901 | 48,530 (0%) | 0% | 0 | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 43.12 per share. | 31 Mar 2024 | 957 | 24,769 (0%) | 0% | 43.1 | 41,266 | Common Stock |
| Synchrony Financial | Zane M. Ellen | Director | Grant, award, or other acquisition of securities at price $ 39.85 per share. | 15 Feb 2024 | 33 | 23,812 (0%) | 0% | 39.8 | 1,315 | Dividend Equivalent Unit |
| Synchrony Financial | Zane Ellen M. | Director | Grant, award, or other acquisition of securities at price $ 38.19 per share. | 31 Dec 2023 | 1,081 | 23,779 (0%) | 0% | 38.2 | 41,283 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 29.16 per share. | 09 Nov 2023 | 45 | 22,698 (0%) | 0% | 29.2 | 1,312 | Dividend Equivalent Unit |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 30.57 per share. | 30 Sep 2023 | 1,350 | 22,653 (0%) | 0% | 30.6 | 41,270 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 34.41 per share. | 10 Aug 2023 | 39 | 21,303 (0%) | 0% | 34.4 | 1,342 | Dividend Equivalent Unit |
| Azenta Inc | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 55.78 per share. | 08 Aug 2023 | 18,766 | 41,134 (0%) | 0% | 55.8 | 1,046,767 | Common Stock |
| Haemonetics Corp. | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2023 | 2,226 | 14,473 (0%) | 0% | - | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 33.92 per share. | 30 Jun 2023 | 1,217 | 21,264 (0%) | 0% | 33.9 | 41,281 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 27.08 per share. | 12 May 2023 | 48 | 20,047 (0%) | 0% | 27.1 | 1,300 | Dividend Equivalent Unit |
| Boston Scientific Corp. | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 3,946 | 45,629 (0%) | 0% | 0 | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 29.08 per share. | 31 Mar 2023 | 1,419 | 19,999 (0%) | 0% | 29.1 | 41,265 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 35.77 per share. | 17 Feb 2023 | 35 | 18,580 (0%) | 0% | 35.8 | 1,252 | Dividend Equivalent Unit |
| Azenta Inc | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2023 | 3,604 | 59,900 (0%) | 0% | 0 | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 32.86 per share. | 31 Dec 2022 | 1,256 | 18,545 (0%) | 0% | 32.9 | 41,272 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 38.73 per share. | 10 Nov 2022 | 30 | 17,289 (0%) | 0% | 38.7 | 1,162 | Dividend Equivalent Unit |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 28.19 per share. | 30 Sep 2022 | 1,464 | 17,259 (0%) | 0% | 28.2 | 41,270 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 36.11 per share. | 11 Aug 2022 | 28 | 15,795 (0%) | 0% | 36.1 | 1,011 | Dividend Equivalent Unit |
| Haemonetics Corp. | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2022 | 2,730 | 12,247 (0%) | 0% | - | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 27.62 per share. | 30 Jun 2022 | 1,494 | 15,767 (0%) | 0% | 27.6 | 41,264 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 33.04 per share. | 12 May 2022 | 24 | 14,273 (0%) | 0% | 33.0 | 793 | Dividend Equivalent Unit |
| Boston Scientific Corp. | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2022 | 4,877 | 41,683 (0%) | 0% | 0 | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 34.81 per share. | 31 Mar 2022 | 1,186 | 14,249 (0%) | 0% | 34.8 | 41,285 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 43.65 per share. | 17 Feb 2022 | 17 | 13,063 (0%) | 0% | 43.6 | 742 | Dividend Equivalent Unit |
| Azenta Inc | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 1,922 | 56,296 (0%) | 0% | 0 | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 46.39 per share. | 31 Dec 2021 | 890 | 13,046 (0%) | 0% | 46.4 | 41,287 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 50.20 per share. | 12 Nov 2021 | 15 | 12,156 | - | 50.2 | 753 | Dividend Equivalent Unit |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 48.88 per share. | 30 Sep 2021 | 844 | 12,141 (0%) | 0% | 48.9 | 41,255 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 51.62 per share. | 12 Aug 2021 | 16 | 11,297 | - | 51.6 | 826 | Dividend Equivalent Unit |
| Haemonetics Corp. | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Aug 2021 | 3,077 | 9,517 (0%) | 0% | - | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 48.52 per share. | 30 Jun 2021 | 696 | 11,281 (0%) | 0% | 48.5 | 33,770 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 45.26 per share. | 13 May 2021 | 23 | 10,586 | - | 45.3 | 1,041 | Dividend Equivalent Unit |
| Boston Scientific Corp. | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2021 | 4,763 | 36,806 (0%) | 0% | 0 | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 40.66 per share. | 31 Mar 2021 | 831 | 10,563 (0%) | 0% | 40.7 | 33,788 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 37.91 per share. | 16 Feb 2021 | 35 | 9,732 | - | 37.9 | 1,327 | Dividend Equivalent Unit |
| Azenta Inc | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 1,760 | 54,374 (0%) | 0% | 0 | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 29.11 per share. | 12 Nov 2020 | 45 | 8,724 | - | 29.1 | 1,310 | Dividend Equivalent Unit |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 26.17 per share. | 30 Sep 2020 | 1,290 | 8,679 (0%) | 0% | 26.2 | 33,759 | Common Stock |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 24.70 per share. | 13 Aug 2020 | 50 | 7,389 | - | 24.7 | 1,235 | Dividend Equivalent Unit |
| Haemonetics Corp. | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2020 | 1,983 | 6,440 (0%) | 0% | - | Common Stock | |
| Synchrony Financial | Ellen M. Zane | Director | Grant, award, or other acquisition of securities at price $ 22.16 per share. | 30 Jun 2020 | 1,524 | 7,339 (0%) | 0% | 22.2 | 33,772 | Common Stock |